| Literature DB >> 31283009 |
Thomas Caffrey1, Satish Sagar1, Divya Thomas1, Michelle E Lewallen2, Michael A Hollingsworth1, Prakash Radhakrishnan1.
Abstract
Aberrant expression of the glycoprotein mucin-1 (MUC1) has been associated with pancreatic cancer progression and metastasis as a result of mediating the oncogenic transcriptional regulation of target genes. In the present study, we demonstrate that MUC1 downregulates the expression of the tumor suppressor polypeptide N-acetylgalactosaminyltransferase 5 in pancreatic cancer. ChIP-on-chip analysis revealed that the MUC1 cytoplasmic tail binds to regulatory elements in the GALNT5 gene. Additionally, MUC1 increases binding of p53 and c-Jun and decreases the binding of Sp1 to the proximal promoter and exonic regions of GALNT5. We also observed that expression of N-acetylgalactosaminyltransferase 5 is inversionally proportional to MUC1 expression in human pancreatic cancer. These results demonstrate that MUC1 downregulates the expression of N-acetylgalactosaminyltransferase 5 in pancreatic cancer by modifying the promoter occupancy of transcription factors through its cytoplasmic domain.Entities:
Keywords: GalNAc-T5; MUC1-CT; glycosyltransferase; pancreatic cancer
Mesh:
Substances:
Year: 2019 PMID: 31283009 PMCID: PMC7048170 DOI: 10.1002/1873-3468.13532
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124